1. Product Overview 1.1. Indication 1.2. Mechanism of Action 1.3. Dosage and Administration 1.4.1 Dosage Forms and Strengths 1.4. Route of Synthesis 1.5. Pharmacology 1.4.2 Pharmacodynamics 1.4.3 Pharmacokinetics 1.6. Adverse Reactions 1.7. Product Snapshot 1.8. Development Milestones of GGS-CIDP 1.9. Marketed Details 1.4.4 United States 1.4.5 Europe 1.4.6 Japan 1.10. Patent Details 2. SWOT Analysis 2.1. Analyst Views 3. Regulatory Milestones 3.1. Approvals 3.2. Research and Development 3.3. Clinical Trials Information 3.4. Safety and Efficacy 3.5. Product Developmental Activities 4. Market Assessment 4.1. 7MM Market Analysis 4.2. United States 4.3. Europe 4.4. Japan 4.5. Key Findings 5. Market Competitors 6. Emerging Therapies 7. Appendix 7.1. Report Purchase Options

Table 1 GGS-CIDP, Description Table 2 GGS-CIDP, Trial Diversification Table 3 GGS-CIDP, Marketed Details United States Table 4 GGS-CIDP, Marketed Details Europe Table 5 GGS-CIDP, Marketed Details Japan Table 6 Patent Details: GGS-CIDP Table 7 GGS-CIDP, Clinical Trial Description, 2020 Table 8 Safety and Efficacy Results for GGS-CIDP Table 9 GGS-CIDP, 7MM Market Size from 2017 to 2030 (in Million USD) Table 10 GGS-CIDP, US Market Size from 2017 to 2030 (in Million USD) Table 11 GGS-CIDP, EU Market Size from 2017 to 2030 (in Million USD) Table 12 GGS-CIDP, EU5 Market Size from 2017 to 2030 (in Millions USD) Table 13 GGS-CIDP, Japan Market Size from 2017 to 2030 (in Million USD) Table 14 Market Competitors Table 15 Emerging Therapies